Opportunities and Challenges in the Development of Genomic Technologies

Genomic technologies have made rapid progress in modern medicine, providing a deeper understanding of the genetic factors that influence health and disease. In Turkey, these technologies have significant potential to transform medical diagnostics, address genetic disorders, and contribute to personalized therapies. This study explores the development, impact, and challenges of genomic technologies in the Turkish healthcare system through a descriptive case study approach. Document analysis and semi-structured interviews with 20 experts, including researchers, healthcare practitioners, and policymakers, were conducted. The findings indicate Turkey’s growing commitment to genomic research, with increased funding allocations and modern facilities. Genomic technologies have significantly improved diagnostic accuracy for genetic disorders and cancer, particularly through Next-Generation Sequencing (NGS) and genomic profiling. However, challenges such as limited funding (only 10% of the healthcare budget), shortage of skilled personnel, and regulatory gaps persist. Despite these barriers, Turkey shows strong potential to become a leader in genomic research. Recommendations for future research include addressing these challenges through increased investment, public awareness campaigns, and workforce development. By overcoming these obstacles, Türkiye can successfully integrate genomic technologies into its healthcare system, improving medical care and promoting personalized treatment